OSRH$0.1628+1.75%
OSR Health, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: BiotechnologyCountry: USExchange: OTC
Mkt Cap:$5.72M
Float & O/S:
Inst Own:
DilutionScan read 29 of OSR Health, Inc.'s SEC filings and found 3 warrant series, 4 convertibles, 1 equity line, 1 S-1 registration and 4 completed offerings on file for OSRH. The latest dilution event on file is an offering on Apr 7, 2026. Analysis updated Oct 16, 2026.
Signal8 Summary
OSRH
Negative cash runway
Snapshot
OSR Holdings is a biotech micro-cap with a shrinking business and negative cash runway. FY 2025 revenue was $2.9M (down 17.7% YoY), and the company lost $18.0M, with a gross margin of 20.4%. Operating cash flow was $-4.3M, and free cash flow was $-4.5M.
What's Happening Right Now
- : CEO Kuk Hyoun Hwang committed to no reverse stock split, providing transparency regarding the company's strategy.
- : OSR Holdings signed an $815 million global license agreement for VXM01 with BCM Europe, reinforcing alignment with public shareholders.
- : OSR Holdings eliminated $2.02 million of warrant overhang by consolidating them into a convertible promissory note.
- : OSR Holdings received a 180-day Nasdaq extension to regain compliance with the minimum $1.00 bid price requirement.
